Location: New York, NY
CIK: 0001582384 · Show all filings
Period: Q3 2017 (← Previous) (Next →)
Filing Date: Nov 15, 2017
Total Value: $558M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | KITE PHARMA INC | 2,410,034 | $433M | 77.7% | $58.66 | — | COM | 49803L109 |
| CSGP | COSTAR GROUP INC | 176,827 | $47.43M | 8.5% | $16.16 | +71.8% | COM | 22160N109 |
| — | NANTKWEST INC | 3,391,539 | $18.59M | 3.3% | $11.46 | — | COM | 63016Q102 |
| LPLA | LPL FINANCIAL HOLDINGS INC | 208,401 | $10.69M | 1.9% | $43.12 | +6.7% | COM | 50212V100 |
| EMB | ISHARES JP MORGAN USD EMERGI | 70,000 | $8.087M | 1.5% | $112.83 | — | JP MOR EM MK ETF | 464288281 |
| SBR | SABINE ROYALTY TRUST | 186,000 | $7.533M | 1.4% | $39.65 | — | UNIT BEN INT | 785688102 |
| — | UNITI GROUP INC | 410,700 | $6.021M | 1.1% | $14.66 | — | COM | 20341J104 |
| MDXG | MIMEDX GROUP INC | 500,000 | $5.94M | 1.1% | $14.83 | 0.0% | COM | 602496101 |
| SRNE | SORRENTO THERAPEUTICS INC | 2,799,790 | $4.76M | 0.9% | $12.08 | -84.8% | COM NEW | 83587F202 |
| URGN | UROGEN PHARMA LTD | 135,000 | $4.255M | 0.8% | $17.36 | +27.1% | COM | M96088105 |
| PLAY | DAVE & BUSTER'S ENTERTAINMEN | 60,000 | $3.149M | 0.6% | $59.48 | 0.0% | COM | 238337109 |
| — | PLAYA HOTELS & RESORTS NV | 300,000 | $3.129M | 0.6% | $11.95 | — | SHS | N70544106 |
| — | CURRENCYSHARES JAPANESE YEN | 31,245 | $2.667M | 0.5% | $86.51 | — | JAPANESE YEN | 23130A102 |
| EDIT | EDITAS MEDICINE INC | 41,324 | $992K | 0.2% | $26.29 | -27.6% | COM | 28106W103 |
| — | NANTHEALTH INC | 238,828 | $984K | 0.2% | $12.47 | — | COM | 630104107 |
| — | ADVERUM BIOTECHNOLOGIES INC | 15,000 | $55,000 | 0.0% | $2.93 | — | COM | 00773U108 |